Investments
2Portfolio Exits
1About The Silverstein Foundation for Parkinson's with GBA
The Silverstein Foundation is a 501(c)(3) non-profit organization focused on investing in cutting-edge therapeutic approaches for the treatment and prevention of Parkinson's disease in glucocerebrosidase (GBA) mutation carriers. The Foundation collaborates with clinicians, scientists, and biotechnology companies to accelerate research and clinical trials in an effort to rapidly bring new disease-modifying therapeutic options to patients.
The Silverstein Foundation for Parkinson's with GBA Headquarter Location
Ansonia Station P.O. Box 237137
New York, New York, 10023,
United States
The Silverstein Foundation for Parkinson's with GBA Investments
2 Investments
The Silverstein Foundation for Parkinson's with GBA has made 2 investments. Their latest investment was in Chamishi Therapeutics as part of their Seed on September 9, 2019.
The Silverstein Foundation for Parkinson's with GBA Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/26/2019 | Seed | Chamishi Therapeutics | $0.49M | Yes | 2 | |
2/26/2019 | Grant |
Date | 9/26/2019 | 2/26/2019 |
|---|---|---|
Round | Seed | Grant |
Company | Chamishi Therapeutics | |
Amount | $0.49M | |
New? | Yes | |
Co-Investors | ||
Sources | 2 |
The Silverstein Foundation for Parkinson's with GBA Portfolio Exits
1 Portfolio Exit
The Silverstein Foundation for Parkinson's with GBA has 1 portfolio exit. Their latest portfolio exit was Gain Therapeutics on March 18, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
3/18/2021 | IPO | Public | 4 |
Date | 3/18/2021 |
|---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | Public |
Sources | 4 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.